Compare ARTNA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARTNA | TKNO |
|---|---|---|
| Founded | 1905 | 1996 |
| Country | United States | United States |
| Employees | 274 | N/A |
| Industry | Water Supply | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 308.3M |
| IPO Year | N/A | 2021 |
| Metric | ARTNA | TKNO |
|---|---|---|
| Price | $34.36 | $4.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.2K | ★ 121.3K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $7.82 | $8.27 |
| Revenue Next Year | $3.54 | $13.13 |
| P/E Ratio | $15.23 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $30.50 | $1.91 |
| 52 Week High | $34.90 | $6.68 |
| Indicator | ARTNA | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 42.61 |
| Support Level | $31.87 | $4.09 |
| Resistance Level | $34.86 | $4.94 |
| Average True Range (ATR) | 0.75 | 0.37 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 69.66 | 13.98 |
Artesian Resources Corp operates as a holding company based in the United States. Through its subsidiaries, it offers water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The Group distributes and sells water, including water for public and private fire protection, to residential, commercial, industrial, municipal, and utility customers. Additionally, it is involved in contract water and wastewater operations; offers wastewater services, and water, sewer, and internal Service Line Protection Plans. The Group operates its businesses mainly through one reportable segment, the Regulated Utility segment.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.